The 23rd International Congress of the European Society of Toxicology In Vitro (ESTIV 2026) was held from June 29 to July 2, 2026, in Maastricht, Netherlands. Focused on the inspiring theme “Ensuring Safety, Advancing Science: Bridging to the Future with New Approach Methodologies (NAMs)”, the congress aimed to explore the transformative impact of NAMs in ensuring safety, fostering innovation, and shaping the future of toxicology.
Team members Nikolina Peranić, PhD, and Mateo Celinić, MPharm, participated in the congress with poster presentations. With her poster presentation titled “Chemical mixture driven androgen receptor disruption”, Nikolina Peranić, PhD, emphasized the importance of studying chemical mixtures. Mateo Celinić, MPharm, presented the latest results in his poster presentation, “Metabolic and cytotoxic readouts differentiate responses of 2D and 3D in vitro pancreatic ductal adenocarcinoma models to 5-fluorouracil and paclitaxel.
